Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01733563
Other study ID # SSB-Effects on metabolism
Secondary ID
Status Recruiting
Phase N/A
First received November 9, 2012
Last updated October 27, 2015
Start date April 2013
Est. completion date December 2015

Study information

Verified date October 2015
Source University of Zurich
Contact Bettina Geidl, PhD
Email bettina.geidl@usz.ch
Is FDA regulated No
Health authority Switzerland: Swissmedic
Study type Interventional

Clinical Trial Summary

The objective of this study is to investigate the impact of sugar sweetened beverages on the fat metabolism of healthy young men. It is well known that consumption of beverages sweetened with fructose is associated with different health risks such as type 2 diabetes. The present study has been designed to dissect differences in the metabolic pathways of fructose and glucose, but also metabolic adaptations during fructose, glucose and sucrose diets. During a period of seven weeks subjects will consume either fructose, glucose or sucrose sweetened beverages or continue their usual drinking habits. During these seven weeks there will be different metabolic investigations using stable isotope tracers. First, the rate of lipolysis and beta-oxidation will be determined. Second, the rates of fatty acid synthesis will be measured. During all examinations there will also be substrate- and energy-utilization measurements by indirect calorimetry, blood analysis and morphometric measurements. Based on the literature main hypotheses are: Fructose enhances de novo lipogenesis postprandially and also in the fasting state significantly more than glucose by enhanced expression of lipogenic enzymes. Fructose decreases beta oxidation via downregulation of oxidative enzymes.


Recruitment information / eligibility

Status Recruiting
Enrollment 96
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 30 Years
Eligibility Inclusion criteria:

- Healthy male volunteers aged 18-30

- BMI between 19-24 kg/m2

- Non-smoker

Exclusion criteria:

- Acute or chronic infections, malignant disease, renal, hepatic (more than two-fold increased transaminases), pulmonary, neurological (epilepsy) or psychiatric diseases, manifested atherosclerosis, or any other disease precluding participation in the study.

- Diabetes

- Known alcohol, substance or drug abuse, concomitant medication

- More than three hours of physical exercise per week

- Consumption of more than 2 times 3 dl SSB daily

- Subjects likely to fail to comply with the study protocol

- Subjects who do not give informed consent

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
Soft drink consumption


Locations

Country Name City State
Switzerland University Hospital Zurich, Endocrinology and Diabetology Zurich ZH

Sponsors (3)

Lead Sponsor Collaborator
University of Zurich SNF Swiss National Foundation, University of Lausanne

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Other Waist/Hip Ratio Measurement waist/hip ratio using a nonstretchable band After total 6 weeks dietary intervention No
Primary Lipogenesis Measurement of lipogenesis is based on i. v. administration of stable isotope labelled acetate (1,2-13C-acetate). 13C incorporation into palmitate is quantified by mass-spectrometry. 13C incorporation correlates to the rate of fatty acid synthesis. After total 6 weeks dietary intervention No
Secondary Lipolysis Measurements using stable isotopes After total 6 weeks dietary intervention No
See also
  Status Clinical Trial Phase
Completed NCT00070577 - Influence of Age and Sex on Alcohol Metabolism and Acute Responses N/A
Active, not recruiting NCT05488574 - Effects of Novel Breathing Behavior Modification Yoga Positioning Integrated Program on Weight Loss N/A
Recruiting NCT05582824 - Lactate Metabolism in the Hypoperfused Critically Ill
Recruiting NCT05443347 - Activity, Adiposity, and Appetite in Adolescents 2 Intervention N/A
Completed NCT05020808 - The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise N/A
Recruiting NCT06082726 - The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers N/A
Completed NCT04144426 - Meal Schedule Effects on Circadian Energy Balance in Adults N/A
Completed NCT03424395 - Personalized Dietary Program and Markers of Wellness N/A
Completed NCT02441296 - Carbohydrate and Metabolism: a Pilot Study N/A
Completed NCT00176085 - Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH Phase 1
Completed NCT00245986 - Effect of Genetics on Metabolism of Efavirenz Phase 4
Completed NCT04025346 - To Evaluate the Efficacy of Capsimax on Metabolic Rate N/A
Completed NCT04078646 - Influence of Proteins on the Bioavailability of Carotenoids N/A
Active, not recruiting NCT06033898 - Inactivity Duration on Lipid Metabolism N/A
Active, not recruiting NCT06250270 - Effects of Casein Protein on Metabolism When Taken Prior to Sleep and in the Morning Early Phase 1
Completed NCT06285578 - Effects of Probiotic and HIIT in Obese Women N/A
Completed NCT04255368 - Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response N/A
Recruiting NCT06360796 - Study of Pharmacokinetics and Metabolism on [(14)C]ADC189 Phase 1
Recruiting NCT02005003 - Cognitive and Metabolic Effects of a Probiotic Supplement N/A
Completed NCT03146728 - Finding the Optimal Voluntary Exercise Parameters for Those Living With Quadriplegia N/A